Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Curr Alzheimer Res

Retrieve available abstracts of 221 articles:
HTML format
Text format



Single Articles


    October 2017
  1. DE OLIVEIRA FF, Chen ES, Smith MC, Bertolucci PHF, et al
    Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer's disease dementia.
    Curr Alzheimer Res. 2017 Oct 16. doi: 10.2174/1567205014666171016101816.
    PubMed     Text format     Abstract available


  2. SUNG PS, Wu MN, Chou PS, Su HC, et al
    Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease patients treated with medication.
    Curr Alzheimer Res. 2017 Oct 10. doi: 10.2174/1567205014666171010112518.
    PubMed     Text format     Abstract available


    September 2017
  3. MANYEVITCH R, Protas M, Scarpiello S, Deliso M, et al
    Evaluation Of Metabolic And Synaptic Dysfunction Hypotheses Of Alzheimer's Disease (Ad): A Meta-Analysis Of Csf Markers.
    Curr Alzheimer Res. 2017 Sep 21. doi: 10.2174/1567205014666170921122458.
    PubMed     Text format     Abstract available


  4. ORTIZ A, Lozano F, Gorriz JM, Ramirez J, et al
    Discriminative Sparse Features for Alzheimer's Disease Diagnosis using multimodal image data.
    Curr Alzheimer Res. 2017 Sep 21. doi: 10.2174/1567205014666170922101135.
    PubMed     Text format     Abstract available


  5. ERDMANN P, Langanke M
    The Ambivalence of Early Diagnosis - Returning results in current Alzheimer research.
    Curr Alzheimer Res. 2017 Sep 7. doi: 10.2174/1567205014666170908101237.
    PubMed     Text format     Abstract available


    August 2017
  6. BUSINARO R, Di Raimo T, Corsi M, Asprino R, et al
    Modulation Of Inflammation As A Way Of Delaying Alzheimer's Disease Progression: The Diet's Role.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829100100.
    PubMed     Text format     Abstract available


  7. GUPTA P, Bhattacharjee S, Sharma AR, Sharma G, et al
    miRNAs in Alzheimer disease - a Therapeutic perspective.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829101016.
    PubMed     Text format     Abstract available


  8. QIAN W, Fischer CE, Schweizer TA, Munoz DG, et al
    Association between psychosis phenotype and APOE genotype on the clinical profiles of Alzheimer's disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829114346.
    PubMed     Text format     Abstract available


  9. MEILAN JJG, Martinez-Sanchez F, Carro J, Carcavilla N, et al
    Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829112439.
    PubMed     Text format     Abstract available


  10. LO VASCO VR
    The Phosphoinositide signal transduction pathway in the pathogenesis of Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Aug 28. doi: 10.2174/1567205014666170829100230.
    PubMed     Text format     Abstract available


    July 2017
  11. LI N, Hu P, Xu T, Chen H, et al
    iTRAQ-based proteomic analysis of APPSw,Ind mice provides insights into the early changes in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jul 19. doi: 10.2174/1567205014666170719165745.
    PubMed     Text format     Abstract available


  12. FUKASAWA JT, Labio RW, Rasmussen LT, Oliveira LC, et al
    CDK5 and MAPT Gene Expression in Alzheimer's Disease Brain Samples.
    Curr Alzheimer Res. 2017 Jul 13. doi: 10.2174/1567205014666170713160407.
    PubMed     Text format     Abstract available


  13. ARENA A, Iyer AM, Milenkovic I, Kovacs GG, et al
    Developmental expression and dysregulation of miR-146a and miR-155 in Down's syndrome and mouse models of Down's syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jul 6. doi: 10.2174/1567205014666170706112701.
    PubMed     Text format     Abstract available


    June 2017
  14. SQUITT R, Simonelli I, Cassetta E, Lupoi D, et al
    Patients with increased non-ceruloplasmin copper appear a distinct sub-group of alzheimer's disease: a neuroimaging study.
    Curr Alzheimer Res. 2017 Jun 23. doi: 10.2174/1567205014666170623125156.
    PubMed     Text format     Abstract available


  15. KOLOSOVA NG, Tyumentsev MA, Muraleva NA, Kiseleva E, et al
    Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
    Curr Alzheimer Res. 2017 Jun 21. doi: 10.2174/1567205014666170621111033.
    PubMed     Text format     Abstract available


  16. PARRA MA, Mikulan E, Trujillo N, Sala SD, et al
    Brain information sharing during visual short-term memory binding yields a memory biomarker for familial Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jun 14. doi: 10.2174/1567205014666170614163316.
    PubMed     Text format     Abstract available


    May 2017
  17. SILVA AR, Pinho MS, Macedo L, Moulin CJA, et al
    The cognitive effects of wearable cameras in Mild Alzheimer disease - An experimental study.
    Curr Alzheimer Res. 2017 May 30. doi: 10.2174/1567205014666170531083015.
    PubMed     Text format     Abstract available


  18. WAMS EJ, Wilcock GK, Foster RG, Wulff K, et al
    Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): A comparison with cognitively healthy adults and moderate Alzheimer's disease patients.
    Curr Alzheimer Res. 2017 May 22. doi: 10.2174/1567205014666170523095634.
    PubMed     Text format     Abstract available


  19. AHMAD J, Akhter S, Rizwanullah M, Khan MA, et al
    Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.
    Curr Alzheimer Res. 2017 May 8. doi: 10.2174/1567205014666170508121031.
    PubMed     Text format     Abstract available


  20. D ORIO B, Fracassi A, Ceru MP, Moreno S, et al
    Targeting Pparalpha In Alzheimer`s Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505094549.
    PubMed     Text format     Abstract available


  21. MARCELLI S, Corbo M, Iannuzzi F, Negri L, et al
    The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095109.
    PubMed     Text format     Abstract available


  22. ZARROUK A, Debbabi M, Bezine M, Karym EM, et al
    Lipid Biomarkers in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505101426.
    PubMed     Text format     Abstract available


  23. ARMAND-UGON M, Ansoleaga B, Berjaoui S, Ferrer I, et al
    Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer's disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095921.
    PubMed     Text format     Abstract available


    April 2017
  24. ALAMEDA-BAILEN JR, Salguero-Alcaniz MP, Merchan-Clavellino A, Paino-Quesada S, et al
    Cognitive Mechanisms In Decision-Making In Patients With Mild Alzheimer Disease.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417113834.
    PubMed     Text format     Abstract available


  25. HE J, Liao T, Zhong GX, Zhang JD, et al
    Alzheimer`s disease-like early-phase brain pathogenesis: Self-curing amelioration of neurodegeneration from pro-inflammatory 'wounding' to anti-inflammatory 'healing'.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111420.
    PubMed     Text format     Abstract available


  26. GAO Y, Tan L, Yu JT, Tan L, et al
    Tau in Alzheimer's disease: Mechanisms and therapeutic strategies.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111859.
    PubMed     Text format     Abstract available


  27. KOJIMA G, Liljas A, Iliffe S, Walters K, et al
    Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417104236.
    PubMed     Text format     Abstract available


  28. VERITE J, Janet T, Julian A, Chassaing D, et al
    Peripheral blood mononuclear cells of Alzheimer's disease patients control CCL4 and CXCL10 levels in a human blood brain barrier model.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417110337.
    PubMed     Text format     Abstract available


    March 2017
  29. SHARIFLOU S, Georgevsky D, Mansour H, Rezaeian M, et al
    Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer`s disease.
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329114445.
    PubMed     Text format     Abstract available


  30. ECHEVERRIA V, Barreto GE, Avila-Rodriguez M, Tarasov VV, et al
    Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329113007.
    PubMed     Text format     Abstract available


  31. DOMINGUES C, da Cruz E Silva OA, Henriques AG
    Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Curr Alzheimer Res. 2017 Mar 17. doi: 10.2174/1567205014666170317113606.
    PubMed     Text format     Abstract available


  32. RODRIGUEZ-CASADO A, Toledano-Diaz A, Toledano A
    Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Curr Alzheimer Res. 2017 Mar 16. doi: 10.2174/1567205014666170316161848.
    PubMed     Text format     Abstract available


  33. POZA J, Gomez C, Garcia M, Tola-Arribas MA, et al
    Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309115656.
    PubMed     Text format     Abstract available


  34. GARRE-OLMO J, Faundez-Zanuy M, Lopez-de-Ipina K, Calvo-Perxas L, et al
    Kinematic and pressure features of handwriting and drawing: preliminary results between patients with mild cognitive impairment, Alzheimer disease and healthy controls.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309120708.
    PubMed     Text format     Abstract available


  35. GARRARD P, Nemes V, Nikolic D, Barney A, et al
    Motif discovery in speech: Application to monitoring Alzheimer's disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309121025.
    PubMed     Text format     Abstract available


    February 2017
  36. SHARMA S, Lipincott W
    Biomarkers in Alzheimer's Disease-Recent Update.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220141822.
    PubMed     Text format     Abstract available


  37. KIM J, Fischer CE, Schweizer TA, Munoz DG, et al
    Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220150021.
    PubMed     Text format     Abstract available


  38. NIXON DW
    The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.
    Curr Alzheimer Res. 2017 Feb 16. doi: 10.2174/1567205014666170216152905.
    PubMed     Text format     Abstract available


  39. DE MARCO M, Vallelunga A, Meneghello F, Varma S, et al
    ApoE epsilon4 allele relateted alterations in hippocampal connectivity in early Alzheimer's disease support memory performance.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206113528.
    PubMed     Text format     Abstract available


  40. WU W, Xie S, Li B, Yang K, et al
    Protective effects of Huang-Lian-Jie-Du-Tang on Abeta25-35-induced memory deficits and oxidative stress in male rats.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206163158.
    PubMed     Text format     Abstract available


  41. NICOLIA V, Ciraci V, Cavallaro RA, Ferrer I, et al
    GSK3beta 5'-flanking DNA methylation and expression in Alzheimer's Disease patients.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203153325.
    PubMed     Text format     Abstract available


  42. LESZEK J, Tse WH, Zhang J, Avila-Rodriguez MF, et al
    Nanotechnology for Alzheimer Disease.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125008.
    PubMed     Text format     Abstract available


  43. MANTZAVINOSA V, Alexiou A, Greig NH, Kamal MA, et al
    Biomarkers for Alzheimer's Disease Diagnosis.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125942.
    PubMed     Text format     Abstract available


  44. AHMAD K, Baig MH, Mushtaq G, Kamal MA, et al
    Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141151.
    PubMed     Text format     Abstract available


  45. REGEN F, Hellmann-Regen J, Costantini E, Reale M, et al
    Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141717.
    PubMed     Text format     Abstract available


  46. SHACKLETON B, Crawford F, Bachmeier C
    Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203093219.
    PubMed     Text format     Abstract available


  47. CHHETRI J, King AE, Gueven N
    Alzheimer's Disease and NQO1: Is there a Link?
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203095802.
    PubMed     Text format     Abstract available


  48. COSTA IB, Labio RW, Rasmussen LT, Viani GA, et al
    Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer s Disease Patients.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203100734.
    PubMed     Text format     Abstract available


    January 2017
  49. DECOURT B, Drumm-Gurnee D, Wilson J, Jacobson S, et al
    Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  50. FUKAMI Y, Ariga T, Yamada M, Yuki N, et al
    Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  51. HULL M, Sadowsky C, Arai H, Le Prince Leterme G, et al
    Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  52. TERZIOGLU-USAK S, Negis Y, Karabulut DS, Zaim M, et al
    Cellular model of Alzheimer's disease: Abeta1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIbeta and Nurr1 expression.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  53. KLIMOVA B, Kuca K
    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review Alzheimer's Disease and Chinese Medicine.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  54. ANNA P, Federico S, Massimo V
    Resilience to Alzheimer's disease: the role of physical activity.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  55. KRANTIC S
    Editorial: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets.
    Curr Alzheimer Res. 2017;14:2-5.
    PubMed     Text format    


  56. LOPEZ-DE-IPINA K, Laske C
    Editorial:Advanced Methods of Biomedical Signal Processing for Early Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2017;14:914-915.
    PubMed     Text format    


  57. SANCHEZ-CATASUS CA, Stormezand GN, van Laar PJ, De Deyn PP, et al
    FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Curr Alzheimer Res. 2017;14:127-142.
    PubMed     Text format     Abstract available


  58. KAMAL MA, Greig NH
    Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives.
    Curr Alzheimer Res. 2017;14:1138-1139.
    PubMed     Text format    


  59. PERCHE F, Uchida S, Akiba H, Lin CY, et al
    Improved Brain Expression of Anti-Amyloid beta scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Curr Alzheimer Res. 2017;14:295-302.
    PubMed     Text format     Abstract available


    December 2016
  60. BRUCKMANN S, Brenn A, Grube M, Niedrig K, et al
    Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  61. YU E, Liao Z, Mao D, Zhang Q, et al
    Directed functional connectivity of posterior cingulate cortex and whole brain in Alzheimer's disease and mild cognitive impairment.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  62. PU YZ, Liang L, Fu AL, Liu Y, et al
    Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation under Control of Zebrafish appb Promotor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    November 2016
  63. MIRZA Z, Beg MA
    Molecular Interactions of Bexarotene - A Retinoid Drug And Alzheimer's Abeta Peptide: A Docking Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  64. ZHU R, Liu X, He Z
    Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  65. ROUCH L, Cestac P, Cool C, Helmer C, et al
    Effectiveness of a standardized and specific follow-up in memory centers in patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  66. IVACHTCHENKO AV, Ivanenkov YA, Veselov MS
    Preclinical evaluation of AVN-322, novel and highly selective 5-HT6 receptor antagonist, for the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  67. SEIDL C, de Moraes Santos CA, De Simone A, Bartolini M, et al
    Uleine disrupts key enzymatic and non-enzymatic biomarkers that leads to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  68. XU DS, Ponce F
    Deep Brain Stimulation for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  69. ZORZETTO M, Datturi F, Divizia L, Pistono C, et al
    Complement C4A and C4B gene copy number study in Alzheimer's disease patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  70. ARCE-VARAS N, Abate G, Prandelli C, Martinez C, et al
    Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer's and Mild Cognitive Impairment patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  71. BOUTAJANGOUT A, Noorwali A, Atta H, Wisniewski T, et al
    Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  72. DECOURT B, Lahiri DK, Sabbagh MN
    Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  73. HSU D, Marshall GA
    Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  74. KAMKWALALA AR, Newhouse PA
    Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  75. GONSALVEZ I, Baror R, Fried P, Santarnecchi E, et al
    Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    August 2016

  76. Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:1198.
    PubMed     Text format     Abstract available


  77. BUDNI J, Garcez ML, de Medeiros J, Cassaro E, et al
    The anti-inflammatory role of minocycline in Alzheimer s Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  78. CYNA M, Lynch M, Oore JJ, Nagy PM, et al
    The benefits of exercise and metabolic interventions for the prevention and early treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  79. VILLETTE V, Dutar P
    GABAergic microcircuits in Alzheimer's disease models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  80. MA K, McLaurin J
    alpha-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  81. MONDRAGON-RODRIGUEZ S, Perry G, Pena-Ortega F, Williams S, et al
    Tau, Amyloid beta and Deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  82. REED BT, Behar-Cohen F, Krantic S
    Seeing early signs of Alzheimer's Disease through the lens of the eye.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  83. CHATTERJEE P, Roy D
    Insight into the epigenetics of Alzheimer's disease: A computational study from human interactome.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  84. DOURADO MC, Laks J
    Psychological Interventions for Neuropsychiatric Disturbances in Mild and Moderate Alzheimer's Disease: Current Evidences and Future Directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  85. SERAFINI G, Calcagno P, Lester D, Girardi P, et al
    Suicide Risk in Alzheimer's Disease: A Systematic Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  86. LIAO Y, Qi XL, Cao Y, Yu WF, et al
    Elevations in the Levels of NF-kappaB and Inflammatory Chemotactic Factors in the Brains with Alzheimer's Disease - One Mechanism May Involve alpha3 Nicotinic Acetylcholine Receptor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    June 2016
  87. TAKAHASHI R, Ishii K, Yokoyama K
    Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  88. CHIARAVALLOTI A, Danieli R, Lacanfora A, Palumbo B, et al
    Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  89. RUB U, Stratmann K, Heinsen H, Del Turco D, et al
    The brainstem tau cytoskeletal pathology of Alzheimer`s disease: A brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  90. ALVES GS, Carvalho AF, de Amorim de Carvalho L, Sudo FK, et al
    Neuroimaging findings related to behavioral disturbances in Alzheimer's disease: a systematic review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  91. CHAKRABARTI SS, Bir A, Poddar J, Sinha M, et al
    Ceramide and sphingosine-1-phosphate in cell death pathways: Relevance to the pathogenesis of Alzheimer`s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  92. WENZLERA S, Knochela C, Balabana C, Krafta D, et al
    Integrated biomarkers for depression in Alzheimer`s disease: a critical review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  93. PEREIRA PA, Alvim-Soares A, Bicalho MA, de Moraes EN, et al
    Lack of association between genetic polymorphism of circadian genes (PER2, PER3, CLOCK and OX2R) with late onset depression and Alzheimer's disease in a sample of a Brazilian population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease).
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  94. FROST S, Guymer R, Aung KZ, Macaulay SL, et al
    Alzheimer`s disease and the early signs of age-related macular degeneration.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  95. KLIMOVA B, Kuca K
    Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  96. TECCHIO F, Vecchio F, Ventriglia M, Porcaro C, et al
    Non-Ceruloplasmin Copper Appears a Disctinct Subtype of Alzheimer`s Disease: A Study of EEG-Derived Brain Activity.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  97. WANG J, Zhang X, Cheng X, Cheng J, et al
    LW-AFC, a herbal medicine for Alzheimer's disease, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in senescence-accelerated mouse prone 8 strain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  98. HEYMANN D, Stern Y, Cosentino S, Tatarina-Nulman O, et al
    The Association Between Alcohol Use and the Progression of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    May 2016
  99. LIU CS, Ruthirakuhan M, Chau SA, Herrmann N, et al
    Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  100. MATURA S, Carvalho AF, Alves GS, Pantel J, et al
    Physical exercise for the treatment of neuropsychiatric disturbances in Alzheimer's dementia: possible mechanisms, current evidence and future directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  101. VAN DAM D, Vermeiren Y, Dekker AD, Naude PJ, et al
    Neuropsychiatric disturbances in Alzheimer's disease: what have we learned from neuropathological studies?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    April 2016
  102. MAGISTRI M, Velmeshev D, Makhmutova M, Patel P, et al
    The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  103. SALAS-GONZALEZ D, Segovia F, Martinez-Murcia FJ, Lang EW, et al
    An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  104. DARVESH S
    Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  105. CINZIA S, Carla P, Pietro C
    Substance P and Alzheimer's disease: emerging novel roles.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  106. QIN L, Chong T, Rodriguez R, Pugazhenthi S, et al
    Glucagon-like peptide-1-mediated modulation of inflammatory pathways in the diabetic brain: Relevance to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  107. DIBATTISTA AM, Heinsinger NM, William Rebeck G
    Alzheimer's Disease Genetic Risk Factor APOE-epsilon4 Also Affects Normal Brain Function.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  108. ZHENG L, Duan J, Duan X, Zhou W, et al
    Association of Apolipoprotein E (ApoE) polymorphism with Alzheimer's Disease in Chinese population.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    March 2016
  109. FRINGS L, Spehl TS, Hull M, Meyer PT, et al
    Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  110. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  111. AL-BADDAI S, Neubauer A, Tome AM, Vigneron V, et al
    Functional Biomedical Images of Alzheimer's Disease a Green's Functionbased Empirical Mode Decomposition Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  112. FRANCOIS M, Fenech MF, Thomas P, Hor M, et al
    High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  113. VIGNERON V, Kodewitz A, Tomeb AM, Lelandais S, et al
    Alzheimer's disease brain areas: the machine learning support for blind localization.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  114. KRASHENYI I, Ramirez J, Popov A, Gorriz JM, et al
    Fuzzy Computer-Aided Alzheimer's Disease Diagnosis Based on MRI Data.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  115. MARTINEZ-MURCIAA FJ, Gorriza JM, Ramireza J, Ortizb For The Alzheimer's Disease Neuroimaging Initiative A, et al
    A Spherical Brain Mapping of MR Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  116. BALI P, Lahiri DK, Banik A, Nehru B, et al
    Potential for Stem Cells Therapy in Alzheimer's disease: Do neurotrophic factors play critical role?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  117. REGE SD, Geetha T, Broderick TL, Babu JR, et al
    Can Diet and Physical Activity limit Alzheimer's disease Risk?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  118. MCNAMARA J, Murray TA
    Connections between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  119. DORSZEWSKA J, Prendecki M, Oczkowska A, Dezor M, et al
    Molecular basis of familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  120. LU W, Yang S, Zhang L, Chen L, et al
    Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  121. FISAR Z, Hroudova J, Hansikova H, Spacilova J, et al
    Mitochondrial respiration in the platelets of patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  122. WEI W, Bodles-Brakhop AM, Barger SW
    A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid beta-Peptide from the Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    February 2016
  123. FERNANDEZ AP, Masa JS, Guedan MA, Futch HS, et al
    Adrenomedullin Expression in Alzheimer's Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  124. RODRIGUEZ JJ, Butt AM, Gardenal E, Parpura V, et al
    Complex and differential glial responses in Alzheimer s disease and ageing.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  125. DJORDJEVIC J, Sabbir MG, Albensi BC
    Traumatic brain injury as a risk factor for Alzheimer's disease: Is inflammatory signaling a key player?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  126. GOLDECK D, Witkowski JM, Fulop T, Pawelec G, et al
    Peripheral immune signatures in Alzheimer Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  127. MARNANE M, Hsiung GR
    Could better phenotyping small vessel disease provide new insights into Alzheimer Disease and improve clinical trial outcomes?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  128. MORRIS G, Berk M
    The Putative Use of Lithium in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  129. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  130. YANG KC, Chen HH
    Probabilistic cost-effectiveness analysis of vaccination for mild or moderate Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  131. GONZALEZ-DOMINGUEZ R, Ruperez FJ, Garcia-Barrera T, Barbas C, et al
    METABOLOMIC-DRIVEN ELUCIDATION OF SERUM DISTURBANCES ASSOCIATED WITH ALZHEIMER S DISEASE AND MILD COGNITIVE IMPAIRMENT.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  132. TANG Z, Liu L, Li Y, Dong J, et al
    Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  133. ZIYATDINOVA S, Ronnback A, Gurevicius K, Miszczuk D, et al
    Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  134. COUNTS SE, He B, Prout JG, Michalski B, et al
    Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  135. DZAMBA D, Harantova L, Butenko O, Anderova M, et al
    Glial cells - the key elements of Alzheimer s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  136. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its pathological role in Alzheimer's disease: Lessons from cell and animal models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  137. HEAD E, Lott IT, Wilcock DM, Lemere CA, et al
    Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
    Curr Alzheimer Res. 2016;13:18-29.
    PubMed     Text format     Abstract available


  138. POTTER H, Granic A, Caneus J
    Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:7-17.
    PubMed     Text format     Abstract available


  139. BARONE E
    Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?
    Curr Alzheimer Res. 2016;13:108-11.
    PubMed     Text format    


  140. CHEN Y, Yan H, Han Z, Bi Y, et al
    Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer's Disease or Mild Cognitive Impairment.
    Curr Alzheimer Res. 2016;13:234-42.
    PubMed     Text format     Abstract available


  141. MA J, Zhang W, Wang HF, Wang ZX, et al
    Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis.
    Curr Alzheimer Res. 2016;13:223-33.
    PubMed     Text format     Abstract available


  142. HUANG Y, Lahiri DK
    Editorial: Translational Alzheimer's Disease Research.
    Curr Alzheimer Res. 2016;13:214.
    PubMed     Text format    


  143. WEINER MW, Gorriz JM, Ramirez J, Castiglioni I, et al
    Editorial: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:466-8.
    PubMed     Text format    


  144. CHOI SS, Lee SR, Lee HJ
    Neurorestorative Role of Stem Cells in Alzheimer's Disease: Astrocyte Involvement.
    Curr Alzheimer Res. 2016;13:419-27.
    PubMed     Text format     Abstract available


  145. TOLEDANO A, Merino JJ, Rodriguez JJ
    Editorial: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy.
    Curr Alzheimer Res. 2016;13:318-20.
    PubMed     Text format    


  146. MAI S
    Editorial: Towards New Approaches in Alzheimer's Research and Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:728-9.
    PubMed     Text format    


  147. DI DOMENICO F, Pupo G, Giraldo E, Lloret A, et al
    Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
    Curr Alzheimer Res. 2016;13:112-22.
    PubMed     Text format     Abstract available


  148. CUI YQ, Wang Q, Zhang DM, Wang JY, et al
    Triptolide Rescues Spatial Memory Deficits and Amyloid-beta Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2016;13:288-96.
    PubMed     Text format     Abstract available


  149. POLJAK A, Crawford JD, Smythe GA, Brodaty H, et al
    The Relationship Between Plasma Abeta Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Curr Alzheimer Res. 2016;13:243-55.
    PubMed     Text format     Abstract available


  150. RIVERA A, Vanzuli I, Arellano JJ, Butt A, et al
    Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?
    Curr Alzheimer Res. 2016;13:413-8.
    PubMed     Text format     Abstract available


  151. HOGENAUER M, Brendel M, Delker A, Darr S, et al
    Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
    Curr Alzheimer Res. 2016;13:597-607.
    PubMed     Text format     Abstract available


  152. BRENDEL M, Reinisch V, Kalinowski E, Levin J, et al
    Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
    Curr Alzheimer Res. 2016;13:475-86.
    PubMed     Text format     Abstract available


  153. VASTA R, Augimeri A, Cerasa A, Nigro S, et al
    Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
    Curr Alzheimer Res. 2016;13:566-74.
    PubMed     Text format     Abstract available


  154. WILKE C, Gillardon F, Deuschle C, Dubois E, et al
    Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Curr Alzheimer Res. 2016;13:654-62.
    PubMed     Text format     Abstract available


  155. IRWIN JA, Erisir A, Kwon I
    Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
    Curr Alzheimer Res. 2016;13:663-77.
    PubMed     Text format     Abstract available


  156. MA C, Zhang Y, Li X, Chen Y, et al
    The TT allele of rs405509 synergizes with APOE epsilon4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
    Curr Alzheimer Res. 2016;13:708-17.
    PubMed     Text format     Abstract available


  157. SALVATORE C, Battista P, Castiglioni I
    Frontiers for the Early Diagnosis of AD by Means of MRI Brain Imaging and Support Vector Machines.
    Curr Alzheimer Res. 2016;13:509-33.
    PubMed     Text format     Abstract available


  158. GALLIVANONE F, Della Rosa PA, Castiglioni I
    Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Curr Alzheimer Res. 2016;13:682-94.
    PubMed     Text format     Abstract available


    December 2015
  159. BECK JS, Mufson EJ, Counts SE
    Evidence for mitochondrial UPR gene activation in familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  160. XU J, Xia LL, Song N, Chen SD, et al
    Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  161. VICKERS JC, Woodhouse A, Fernandez-Martos CM, Kirkcaldie MT, et al
    Defining the earliest pathological changes of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  162. BU XL, Jiao SS, Lian Y, Wang YJ, et al
    Perspectives on the tertiary prevention strategy for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  163. ESTERAS N, Alquezar C, de la Encarnacion A, Martin-Requero A, et al
    Lymphocytes in Alzheimer's disease pathology: Altered signaling pathways.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  164. TEJERA D, Heneka MT
    Microglia in Alzheimer's disease: the good, the bad and the ugly.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  165. BERGERON D, Bensaidane R, Laforce R Jr
    Untangling Alzheimer's disease clinicoanatomical heterogeneity through selective network vulnerability - an effort to understand a complex disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  166. BESGA-BASTERRA A, Chyzhyk D, Gonzalez-Ortega I, Savio A, et al
    Eigenanatomy on fractional anisotropy imaging provides white matter anatomical features discriminating between Alzheimer's Disease and Late Onset Bipolar Disorder.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  167. MERINO JJ, Muneton-Gomez V, Alvarez MI, Toledano-Diaz A, et al
    Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in Alzheimer,s disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  168. LIM D, Rodriguez-Arellano JJ, Parpura V, Zorec R, et al
    Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  169. CARMONA P, Molina M, Toledano A
    Blood-based biomarkers of Alzheimer s disease: diagnostic algorithms and new technologies.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  170. TOLEDANO A, Alvarez MI, Toledano-Diaz A, Merino JJ, et al
    Brain local and regional neuroglial alterations in Alzheimer s Disease: cell types, responses and implications.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  171. SU L, Blamire AM, Watson R, He J, et al
    Cortical and subcortical changes in Alzheimer's disease: a longitudinal and quantitative MRI study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  172. SEGOVIA F, G'orriz JM, Ram'irez J, Phillips C, et al
    Combining feature extraction methods to assist the diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  173. MARTINEZ-MURCIA FJ, Gorriz JM, Ramirez J, Ortiz A, et al
    A Statistical Projection of MRI Brain Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  174. ZIPPO AG, Castiglioni I
    Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    October 2015
  175. HERRAN E, Perez-Gonzalez R, Igartua M, Pedraz JL, et al
    Enhanced hippocampal neurogenesis in APP/Ps1 mouse model of Alzheimer's disease after implantation of VEGF-loaded PLGA nanospheres.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  176. KARA F, Hofling C, Rossner S, Schliebs R, et al
    In vivo longitudinal monitoring of changes in the corpus callosum integrity during disease progression in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  177. RASMUSSEN L, Delabio R, Viani GA, Chen E, et al
    Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  178. ZIVKOVIC L, Bajic V, Perry G, Spremo-Potparevica B, et al
    Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  179. LIN TW, Liu YF, Shih HS, Chen SJ, et al
    Neurodegeneration in amygdala precedes hippocampus in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  180. WIESMANN M, Capone C, Zerbi V, Mellendijk L, et al
    Hypertension impairs cerebral blood flow in a mouse model for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  181. BOIOCCHI C, Maggioli E, Monti MC, Zorzetto M, et al
    The Possible Involved of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  182. SALEHI A, Ashford JW, Mufson EJ
    Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.
    Curr Alzheimer Res. 2015.
    PubMed     Text format    


    September 2015
  183. HAMLETT E, Boger HA, Ledreux A, Kelley CM, et al
    Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  184. PHILLIPS C, Fahimi A, Das D, Mojabi FS, et al
    Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  185. IULITA MF, Claudio Cuello CA
    The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  186. STRUPP BJ, Powers BE, Velazquez R, Ash JA, et al
    Maternal choline supplementation:A potential prenatal treatment for Down syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  187. SERINI S, Calviello G
    Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  188. LLORET A, Fuchsberger T, Giraldo E, Vina J, et al
    Reductive stress: A new concept in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  189. GIUDETTI AM, Romano A, Lavecchia AM, Gaetani S, et al
    The role of brain cholesterol and its oxidized products in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    July 2015
  190. COUPLAND KG, Kim WS, Halliday GM, Hallupp M, et al
    Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  191. INEKCI D, Henriksen K, Linemann T, Karsdal MA, et al
    Serum fragments of Tau for the differential diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  192. BEAUCHET O, Cp L, Montero-Odasso M, Annweiler C, et al
    Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  193. SUI X, Zhu M, Cui Y, Yu C, et al
    Functional connectivity hubs could serve as a potential biomarker in Alzheimer's disease: a reproducible study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  194. CHENG XR, Cui XL, Zheng Y, Zhang GR, et al
    A co-module regulated by therapeutic drugs in a molecular subnetwork of Alzheimer's disease identified on the basis of traditional Chinese medicine and SAMP8 mice.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  195. EL HAJ M, Raffard S, Antoine P, Gely-Nargeot MC, et al
    Emotion and destination memory in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  196. PLAGG B, Ehrlich D, Kniewallner KM, Marksteiner J, et al
    Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic Alzheimer's mice and in human patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  197. FERRARI R, Ferrara M, Alinani A, Sutton RB, et al
    Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  198. NUZZO D, Picone P, Baldassano S, Caruana L, et al
    Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  199. ZHANG Y, Wang F, Luo X, Wang L, et al
    Cognitive improvement by photic stimulation in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  200. VOLGYI K, Juhasz G, Kovacs Z, Penke B, et al
    Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  201. WALDRON A, Wyffels L, Verhaeghe J, Bottelbergs A, et al
    Quantitative muPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  202. YASUE M, Sugiura S, Uchida Y, Otake H, et al
    Prevalence of Sinusitis Detected by Magnetic Resonance Imaging in Subjects with Dementia or Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    May 2015
  203. CM K, Jh W, Jm L, Jh R, et al
    Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  204. Q Z, Q G, X L, M C, et al
    Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  205. B Z
    Prevention strategies targeting different preclinical stages of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    January 2015
  206. JEONG YJ, Kang GY, Kwon JH, Choi HD, et al
    1950 MHz Electromagnetic Fields Ameliorate Abeta Pathology in Alzheimer's Disease Mice.
    Curr Alzheimer Res. 2015;12:481-92.
    PubMed     Text format     Abstract available


  207. DEZSI L, Tuka B, Martos D, Vecsei L, et al
    Alzheimer's disease, astrocytes and kynurenines.
    Curr Alzheimer Res. 2015;12:462-80.
    PubMed     Text format     Abstract available


  208. MA DL, Leung CH
    Editorial: small molecule therapeutics for Alzheimer's disease.
    Curr Alzheimer Res. 2015;12:400-2.
    PubMed     Text format    


  209. RASKIN J, Cummings J, Hardy J, Schuh K, et al
    Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions.
    Curr Alzheimer Res. 2015;12:712-22.
    PubMed     Text format     Abstract available


  210. MARESOVA P, Mohelska H, Dolejs J, Kuca K, et al
    Socio-economic Aspects of Alzheimer's Disease.
    Curr Alzheimer Res. 2015;12:903-11.
    PubMed     Text format     Abstract available


  211. LAHIRI DK
    View of excellent ROAD from the CAR.
    Curr Alzheimer Res. 2015;12:96-9.
    PubMed     Text format    


  212. ZHANG Y, Zou J, Yang J, Yao Z, et al
    4Abeta1-15-Derived Monoclonal Antibody Reduces More Abeta Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Curr Alzheimer Res. 2015;12:384-97.
    PubMed     Text format     Abstract available


  213. CHAO F, Zhang L, Luo Y, Xiao Q, et al
    Running Exercise Reduces Myelinated Fiber Loss in the Dentate Gyrus of the Hippocampus in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2015;12:377-83.
    PubMed     Text format     Abstract available


  214. ANTES R, Salomon-Zimri S, Beck SC, Garcia Garrido M, et al
    VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
    Curr Alzheimer Res. 2015;12:323-34.
    PubMed     Text format     Abstract available


  215. DEACON RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, et al
    Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.
    Curr Alzheimer Res. 2015;12:314-22.
    PubMed     Text format     Abstract available


  216. WONG CY, Chung LH, Lu L, Wang M, et al
    Dual Inhibition And Monitoring Of Beta-amyloid Fibrillation By A Luminescent Iridium(III) Complex.
    Curr Alzheimer Res. 2015;12:439-44.
    PubMed     Text format     Abstract available


  217. KOCHI A, Lee HJ, Vithanarachchi SM, Padmini V, et al
    Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-beta Aggregation.
    Curr Alzheimer Res. 2015;12:415-23.
    PubMed     Text format     Abstract available


    January 2014
  218. ALBERT M, Soldan A, Gottesman R, McKhann G, et al
    Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.
    Curr Alzheimer Res. 2014;11:773-84.
    PubMed     Text format     Abstract available


  219. WAKEFIELD SJ, McGeown WJ, Shanks MF, Venneri A, et al
    Differentiating normal from pathological brain ageing using standard neuropsychological tests.
    Curr Alzheimer Res. 2014;11:765-72.
    PubMed     Text format     Abstract available


  220. WANG J, Zhang Y, Xu H, Zhu S, et al
    Fluoxetine improves behavioral performance by suppressing the production of soluble beta-amyloid in APP/PS1 mice.
    Curr Alzheimer Res. 2014;11:672-80.
    PubMed     Text format     Abstract available


  221. IYER AM, van Scheppingen J, Milenkovic I, Anink JJ, et al
    Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Curr Alzheimer Res. 2014;11:694-705.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: